KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Acquisitions: 2009-2024

Historic Acquisitions for Charles River Laboratories International (CRL) over the last 7 years, with Jun 2024 value amounting to $5.5 million.

  • Charles River Laboratories International's Acquisitions was N/A to $5.5 million in Q2 2024 from the same period last year, while for Jun 2024 it was $483.7 million, marking a year-over-year change of. This contributed to the annual value of $5.5 million for FY2024, which is 97.19% down from last year.
  • As of Q2 2024, Charles River Laboratories International's Acquisitions stood at $5.5 million, which was down 96.21% from $144.6 million recorded in Q4 2023.
  • In the past 5 years, Charles River Laboratories International's Acquisitions ranged from a high of $906.3 million in Q2 2021 and a low of -$518,000 during Q4 2020.
  • In the last 3 years, Charles River Laboratories International's Acquisitions had a median value of $97.4 million in 2023 and averaged $120.9 million.
  • The largest annual percentage gain for Charles River Laboratories International's Acquisitions in the last 5 years was 38,550.15% (2020), contrasted with its biggest fall of 1,059.26% (2020).
  • Quarterly analysis of 5 years shows Charles River Laboratories International's Acquisitions stood at -$518,000 in 2020, then surged by 293.44% to $1.0 million in 2021, then slumped by 68.73% to $283.4 million in 2022, then reached $144.6 million in 2023, then reached $5.5 million in 2024.
  • Its last three reported values are $5.5 million in Q2 2024, $144.6 million for Q4 2023, and $50.2 million during Q2 2023.